• Diagnóstico cáncer de próstata: Técnicas emergentes, imagen y nuevos marcadores.
  • Tratamiento del tumor vesical no invasivo. Utilidad de quimioterapia, hipertermia, inmunoterapia para evitar recurrencias y progresión.
Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study.
Morote, Juan, Gomez-Caamano, Antonio, de Celis, Raul Poza, Gomez-Veiga, Francisco, Ciria, Juan P., Calleja, Jesus, Extramiana, Javier, Perez-Sampietro, Maria, Perrot, Valerie, Angulo, Javier C., ANALUTS Study Group.

NEUROUROLOGY AND URODYNAMICS, 41, 1824-1833. 2022
Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)..
Valero, J, Peleteiro, P, Henriquez, I, Conde, A, Piquer, T, Lozano, A, Soler, CC, Muñoz J, Illescas, A, Jove, J, Flores, MM, Baquedano, J, Diezhandino, P, de Celis, RP, Pardo, EH, Samper, P, Villoslada, I, Eguiguren, M, Millan, V.

CLINICAL & TRANSLATIONAL ONCOLOGY, 22, 1378-1389. 2020
Safety and outcomes of new generation hormone-therapy in elderly chemotherapy-naive metastatic castration-resistant prostate cancer patients in the real world.
Beardo P., Osman I., San José B., Llarena R., Congregado B., Campá J., Medina-López R.A., Extramiana J..

ARCHIVES OF GERONTOLOGY AND GERIATRICS, 82, 179-185. 2019

Coordinador de Área:
Dr. Josep María Campá Bortoló